Author:
Fiehn C.,Leipe J.,Weseloh C.,Bergner R.,Krüger K.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Filkova M, Carvalho J, Norton S et al (2017) Polypharmacy and unplanned hospitalizations in patients with rheumatoid arthritis. J Rheumatol 44:1786–1179
2. Fiehn C (2016) Pharmakologie von Methotrexat. In: Müller-Ladner U, Rau R (eds) Methotrexat bei Autoimmunerkrankungen – moderne Therapiekonzepte in der Rheumatologie, Dermatologie und Gastroenterologie, 1 edn. UNI-MED, Bremen, pp 23–29
3. Lim AY, Gaffney K, Scott DG (2005) Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. Rheumatology 44(8):1051–1055
4. Bourré-Tessier J, Haraoui B (2010) Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 37(7):1416–1421
5. Kwon OC, Lee JS, Kim YG et al (2018) Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole. Clin Rheumatol 37(12):3215–3220